Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-27 @ 10:57 PM
Study NCT ID:
NCT06298968
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-25
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-01
First Submit QC Date:
None
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-30
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL